FdaApplication
ANDA 207610
Identifiers
- fda_app_no: ANDA207610
Properties
| Property | Value |
|---|---|
| applicant_name | EPIC PHARMA LLC |
| application_type | ANDA |
| approval_date | 2019-05-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AZELASTINE HYDROCHLORIDE | AZELASTINE HYDROCHLORIDE | 0.137MG/SPRAY | SPRAY, METERED;NASAL |
1 product